Another study conducted by Núñez et al. [68] showed that in the context of ATRX loss, IDH mutant cancers enhance DNA damage response via the up-regulation of the ATM pathway, suggesting that ATRX deficiency in diffusive astrocytoma may affect DNA repair pathways and sensitivity to therapy. Here, IDH2 is linked to astrocytoma (excluding glioblastoma).